In the case of rBCCs, it has been made clear from this work that SMOi can lead to an accumulation of LY6D+ cells suggesting that drug intervention may drive LY6D+ cells into a similar state capable of giving rise to an SCC-associated tumor epithelium. The gene discussed is LY6D; the disease is neoplasm.